Sangamo Therapeutics Inc.

09/22/2022 | Press release | Distributed by Public on 09/22/2022 15:05

PFIZER AND SANGAMO THERAPEUTICS ANNOUNCE PHASE 3 TRIAL OF INVESTIGATIONAL GENE THERAPY FOR HEMOPHILIA A HAS RE-OPENED RECRUITMENT